190 likes | 561 Views
When To Suspect Lymphoma. 1. Patients with impaired immune systems HIV, Transplant, Auto immune diseases 2. Patients with unexplained fever, night sweats, weight loss 3. Patients with lymphadenopathy. Lymphadenopathy. Medicine 79:338 47, 2000 Biopsy or not Ne
E N D
1. Lymphoma for the Internist Lee Berkowitz, MD
Oct 2, 2007
2. When To Suspect Lymphoma 1. Patients with impaired immune systems
HIV, Transplant, Auto immune diseases
2. Patients with unexplained fever, night sweats, weight loss
3. Patients with lymphadenopathy
3. Lymphadenopathy Medicine 79:338 47, 2000 Biopsy or not
Neg Positive
Tenderness Generalized Pruritus
Size < 1cm Supraclavicular
Hard
4. Non-Hodgkins
5. Hodgkins
6. How to make the Diagnosis
FNA
Biopsy
7. Hodgkins Lymphocyte Predominant
Nodular Sclerosing
Mixed Cellularity
Lymphocyte Depleted
8. Non-Hodgkins The indolent lymphomas B-cell neoplasms Small lymphocytic lymphoma/B-cell chronic lymphocytic leukemia Lymphoplasmacytic lymphoma (ą Waldenstrom's macroglobulinemia) Plasma cell myeloma/plasmacytoma Hairy cell leukemia Follicular lymphoma (grade I and II) Marginal zone B-cell lymphoma Mantle cell lymphoma T-cell neoplasms T-cell large granular lymphocyte leukemia Mycosis fungoides T-cell prolymphocytic leukemia Natural killer cell neoplasms Natural killer cell large granular lymphocyte leukemia
The aggressive lymphomas B-cell neoplasms Follicular lymphoma (grade III) Diffuse large B-cell lymphoma Mantle cell lymphoma T-cell neoplasms Peripheral T-cell lymphoma Anaplastic large cell lymphoma, T/null cell
The highly aggressive lymphomas B-cell neoplasms Burkitt's lymphoma Precursor B lymphoblastic leukemia/lymphoma T-cell neoplasms Adult T-cell lymphoma/leukemia Precursor T lymphoblastic
9. Staging I. 1 nodal group
II. 2 nodal groups on the same side of the diaphragm
III. Disease above and below the diaphragm
IV. Disease in other organs
10. Staging Physical examination
CT scans
Bone marrow biopsies
11. StagingHodgkins I. 15%
II. 35%
III.35%
IV.15%
12. Staging Non-Hodgkins Low Grade
I-II
III- IV
13. Staging Non-Hodgkins Low-Grade
I-II 5%
III-IV 95%
14. StagingNon-Hodgkins Intermediate Grade
I-II 30%
III-IV 70%
15. TreatmentHodgkins Stage I Cure with radiation therapy
Stage II, III, IV Cure with chemotherapy
16. TreatmentNon-Hodgkins Intermediate and High-grade Cure with chemotherapy
17. TreatmentNon-Hodgkins Low Grade
18. Treatment Low-grade 1. These cells over express bcl 2
2. The median survival for these patients untreated is 8 years
19. TreatmentNon-Hodgkins Low-grade 1. Observation
2. Standard chemo
3. Monoclonal antibodies rituximab
4. Stem-cell transplants